Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2009-05-01

FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's supplemental application for glyburide, resulting in a labeling update for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glyburide (glyburide)

Snippet

SUPPL AP for GLYBURIDE (GLYBURIDE)